Wyeth Lederle Vaccines SA
Wyeth Lederle Vaccines reported total assets of 515,975 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Jun 2026).
By total assets for 2025, Wyeth Lederle Vaccines ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Wyeth Lederle Vaccines shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6 % Total assets +7 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Wyeth Lederle Vaccines's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 2,050 € | ||||
| Equity | 510,147 € | ||||
| Cash | 26,718 € | ||||
| EBITDA | −8,654 € | ||||
| Total assets | 515,975 € |
Filed annual accounts
- Year ended 30 Nov 2025filed on 02 Jun 2026
- Year ended 30 Nov 2024filed on 23 May 2025
- Year ended 30 Nov 2023filed on 21 May 2024
- Year ended 30 Nov 2022filed on 23 May 2023
- Year ended 30 Nov 2021filed on 01 Jun 2022
Wyeth Lederle Vaccines's financial analysis
- Solvency98.9%sector median: 48.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Wyeth Lederle Vaccines
Wyeth Lederle Vaccines's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0460.950.631
- VAT number
- BE0460950631
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SA
- Incorporated
- 27 Jun 1997
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 02 Jun 2026
- Activity
- Research and experimental development on other natural sciences and engineering (NACE 7210901)
Wyeth Lederle Vaccines (SA) has been based in Ixelles since 1997, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net profit of 2,050 € and equity of 510,147 €; its revenue is not published. Its solvency stands at 98.9%, above the median of its sector (48.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Wyeth Lederle Vaccines
Companies in the same business, of comparable size and area, outside its group.
- Grenadilla Silviculture and other forestry activities Antwerp · balance sheet 516,078 €
- Thuisverpleging Sonja Hilven Nursing and midwifery activities Maaseik · balance sheet 515,705 €
- KNLCL Activities of holding companies Jette · balance sheet 516,251 €
- ASD Investment Activities of holding companies Zwevegem · balance sheet 516,661 €
- Puppy Exploitation Activities of holding companies Rixensart · balance sheet 516,752 €
- Solemi Activities of agents involved in the wholesale of other particular products Watermael-Boitsfort · balance sheet 516,752 €
- RB Immobilier Buying and selling of own real estate Uccle · balance sheet 515,178 €
- European Reproduction Service Pre-press and pre-media services Woluwe-Saint-Pierre · balance sheet 517,149 €
Frequently asked questions about Wyeth Lederle Vaccines
What is the revenue of Wyeth Lederle Vaccines?
Wyeth Lederle Vaccines files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Wyeth Lederle Vaccines?
In Belgium, the VAT number is the company number prefixed with BE: BE0460950631 for Wyeth Lederle Vaccines, if the company is VAT-registered. Its company number (CBE) is 0460.950.631.
Where is the registered office of Wyeth Lederle Vaccines?
According to the CBE register, the registered office of Wyeth Lederle Vaccines is in 1050 Ixelles.
What is the equity of Wyeth Lederle Vaccines?
At the close of the 2025 financial year, the equity of Wyeth Lederle Vaccines amounts to 510,147 €, a solvency of 98.9% of total assets.
Who manages Wyeth Lederle Vaccines?
The register lists 2 active mandates at Wyeth Lederle Vaccines. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Wyeth Lederle Vaccines within its sector?
By total assets for 2025, Wyeth Lederle Vaccines ranks in the top half of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Wyeth Lederle Vaccines
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →